Fitaro 1 mg/0.5 ml (SC Injection)

1 mg pre-filled syringe: ৳ 1,000.00

Medicine Details

Category Details
Generic Semaglutide
Company Incepta pharmaceuticals ltd
Also available as
Orsema 05 mg injection Orsema 025 mg injection Fitaro 17 mg injection Fitaro 24 mg injection Fitaro 025 mg injection Fitaro 05 mg injection

Title

  • Fitario Medication

Categories

  • Diabetes Management
  • Weight Management

Description

  • Semaglutide tablet for glycemic control
  • Semaglutide injection for weight management

Indications

  • Adjunct to diet and exercise for type 2 diabetes mellitus
  • Reducing risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus
  • Chronic weight management in adults with obesity or overweight

Pharmacology

  • Selective GLP-1 receptor agonist
  • Reduces blood glucose in a glucose-dependent manner
  • Stimulates insulin secretion
  • Lowers glucagon secretion
  • Delays gastric emptying
  • Reduces appetite and body weight

Dosage & Administration

  • Take at least 30 minutes before first food or drink
  • Starter dose: 3 mg once daily for 30 days
  • Maintenance dose: Increase to 7 mg once daily after 30 days on 3 mg dose
  • Additional glycemic control: Dose may be increased to 14 mg once daily if needed
  • Injections recommended weekly, subcutaneously in abdomen, thigh, or upper arm
  • Starting dose for obesity: 0.25 mg once weekly for 4 weeks, then escalated to 2.4 mg
  • Dose adjustment instructions for switching between tablet and injection

Interaction

  • Delays gastric emptying and can impact absorption of concomitantly administered oral medicinal products

Contraindications

  • Hypersensitivity to active substance or excipients

Side Effects

  • Hypoglycemia, gastrointestinal disorder, nausea, diarrhea, vomiting, abdominal pain, constipation, allergic reaction, injection site reaction, lipodystrophy, pruritus, rash

Pregnancy & Lactation

  • Not recommended during pregnancy
  • Discontinue at least 2 months before planned pregnancy
  • Not recommended during breastfeeding

Precautions & Warnings

  • Not to be used in type 1 diabetes mellitus or for treatment of diabetic ketoacidosis
  • Discontinue promptly if pancreatitis is suspected
  • Monitoring required for patients with diabetic retinopathy

Use in Special Populations

  • Safety and efficacy not established in children and adolescents below 18 years
  • No dose adjustment based on age
  • No dose adjustment for mild, moderate, or severe renal impairment
  • Not recommended for end-stage renal disease
  • No dose adjustment for hepatic impairment, exercise caution

Overdose Effects

  • Reported overdose reactions and appropriate supportive treatment
  • Dose adjustment considerations for existing medication therapies
  • Instructions for missed doses

Therapeutic Class

  • GLP-1 receptor agonists

Storage Conditions

  • Store at 2°C to 8°C (in a refrigerator)
  • Do not freeze
  • Keep out of reach of children

Related Brands